Back to Trades
Garfield Alastair
Chief Scientific OfficerCIK 0002027261
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2026
Garfield Alastair, Chief Scientific Officer, has filed 3 SEC reports (2026), all concentrated in RHYTHM PHARMACEUTICALS, INC. (RYTM), totaling $3.6M in disclosed volume. Weighing $0 bought versus $912.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 17 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Sell | $912.7K |
| Jul 2 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Exercise | $237.4K |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Award | $2.5M |
3 filings